Franklin Templeton’s Notes from the Trading Desk offers a weekly overview of what their professional traders and analysts are watching in the markets. The European desk is manned by eight professionals based in Edinburgh, Scotland, with an average of 15 years of experience whose job it is to monitor the markets around the world. Their views are theirs alone and are not intended to be construed as investment advice.
Last week equity markets remained volatile as investors focused on the Omicron variant headlines and rhetoric from central bankers. In particular, commentary from the Federal Reserve (Fed) was a key talking point as Chair Jerome Powell suggested the pace of Fed tapering could be accelerated. In that context, indices started off December with a distinctly unfestive performance, with the MSCI World Index down 1.5%, the European Stoxx 600 Index down 0.3%, the S&P 500 Index down 1.2% and the MSCI Asia Pacific Index down1%.
Last week equity markets were at the mercy of the next Omicron variant headline as investor sentiment wavered around the potential impact of the new variant on global economies and markets.
Whilst there has been a lot of noise around the new variant, we are still waiting for full clarity on the severity of illness, vaccine efficacy and the likelihood of reinfection. However, cases continued to rise sharply in South Africa and further cases are appearing globally. As a result, some travel restrictions are returning, and the newsflow around variant concerns was enough for some economist to cut their global gross domestic product (GDP) forecasts.
It is important to remember that nerves were already frayed last week over COVID-19 as cases rose sharply in some places, namely Austria and Germany. Some countries have already added restrictions on travel and recreation, and last week saw further negative COVID-19 headlines from Germany weigh on sentiment as the government announced tighter restrictions on unvaccinated people. Chancellor Angela Merkel said “the situation is very serious. The number of infections has stabilised but at far too high a level.”
How the current situation impacts economic activity will be key, as early mobility numbers show declines in retail footfall in affected countries and flight bookings have decreased.
December will be an interesting month for central banks as soaring inflation puts pressure on them to act. However, the waters are muddied significantly by the arrival of Omicron and the potential for disruption to economic activity.
Looking ahead this month, we have a number of central bank meetings on the calendar. The Bank of Canada and Reserve Bank of Australia meet this week, whilst the Federal Reserve, meeting and the Bank of England (BoE) and the European Central Bank (ECB) hold policy meetings next week.
ECB: Nobody thought that the ECB was moving any time soon, but President Christine Lagarde said last Friday that an interest rate rise in 2022 was very unlikely. She also confirmed that net purchases under its €1.85 trillion Pandemic Emergency Purchase Programme (PEPP) will likely expire on schedule at the end of March 20211. She also said the central bank may unveil short-term measures at December’s policy meeting due to heightened uncertainty, providing some clarity without making long-term commitments. So, it looks like the 16 December meeting may be a non-event, with eyes being focused on the 3 February and 10 March 2022 meetings, when we might see the bank scaling up its standard Asset Purchase Programme (APP) to make it more flexible upon the end of PEPP net purchases.
Despite European Union (EU) inflation hitting a record level of 4.9% (last week’s Consumer Prices Index (CPI) data), Lagarde feels this is peaking and will start to pare back in 2022.
Fed: Probably of more significance last week were Fed Chair Powell’s remarks suggesting that the term “transitory” should no longer be used, which added to expectations that the first US rate hike could be sooner than anticipated. He went on to say the Fed can consider wrapping up taper a few months sooner and must ensure higher inflation doesn’t become entrenched. That said, the November jobs data (released on Friday) did not look especially inflationary, besides the headline unemployment rate, with the Institute of Supply Management (ISM) data this week also on the softer side.
In this context, we have seen a sharp flattening of the US Treasury yield curve in recent weeks, with the curve now at levels similar to March 2020.
With Powell’s hawkish pivot, market expectations of rate hikes have risen, and expectations are for interest rates to hit 1.25% by the end of 2023.
BoE: An interest rate increase was very much expected at the last monetary policy meeting on 4 November, but did not transpire, and we saw UK banks decline. Comments last Friday from traditionally hawkish BoE member Mike Saunders surprised markets somewhat as he stated there were “advantages” to waiting for more information on Omicron before acting on rates.
With that, the British pound traded lower, gilts edged higher, and expectations of a rate rise on 16 December waned. Based on trading in interest rate futures, investors now see a 25% chance that the BoE will lift the base rate from 0.10% to 0.25%. Before he spoke, the probability stood at 50%, having already fallen significantly since the emergence of Omicron a week ago.
However, looking further ahead, Saunders said interest rates were likely to rise from their present historic lows over the coming months: “If the economy develops as I expect, then some additional tightening, on top of such a move, probably will be needed fairly soon.”
European equities ended the week essentially unchanged, but mildly negative. However, that doesn’t tell the story of what was a volatile trading period, as markets nerves were brittle and we were very much at the mercy of the next COVID-19 headline.
With that, the European Volatility Index remained at elevated levels. It also felt like moves were exaggerated as we navigated month end, but also as we approach the year end and investors grow nervous about protecting performance.
Looking to sector performance, despite a volatile week for crude oil, oil and gas stocks were higher. On the downside, telecommunications and technology stocks were lower.
Credit: Looking beyond equities, it is noteworthy that European credit spreads widened on the Omicron news and have remained at somewhat elevated levels. We see this as a good barometer for investor sentiment and something to keep an eye on.
US equities declined for last week as Omicron concerns rattled nerves and as Powell stuck by his recent hawkish tilt. The pain was greatest in growth names (particularly technology) as investors factored in a faster Fed tightening cycle.
Volatility remains high—on Wednesday of last week, the S&P 500 Index saw its largest intraday swing since March. As in Europe, the US Volatility index remains elevated, with the VIX Index around the 30 level.
Looking to Fed speak beyond Powell, Loretta Mester (a non-voter) said she is “very open” to scaling back asset purchases at a faster pace so the Fed can raise interest rates a couple of times next year if necessary. In addition, Mary Daly (also a non-voter) also said that the Fed may need to taper asset purchases more quickly.
Fund flows for the week to 1 December also carried a risk off tone, with investors moving largely to cash and US Treasuries.
It was also interesting to see retail investor favourites suffering in this risk-off climate, as crowded trades saw outflows. Given “buy the dip” has become a familiar mantra for some investors in recent times, it will be interesting to see if this behaviour continues into year end..
As with other regions, uncertainty over the Omicron variant and travel restrictions weighed on sentiment for Asian equities, with the MSCI Asia Pacific Index down last week. The Nikkei was hardest hit, as Japan banned foreign visitors once again.
South Korea was the best performing index in the region, rising on the back of a strong week for heavyweight Samsung.
In Hong Kong, the Macau gaming sector dragged the market lower.
In terms of macro data, China Purchasing Manager Index (PMI) prints were mixed; the Caixin PMI Composite came in at 51.2 vs. 51.5 prior while Caixin PMI Manufacturing came in at a weaker-than-expected at 49.9.
Equity markets are off to a positive start this week in Europe as Dr Anthony Fauci, US President Joe Biden’s chief medical adviser, said early data on Omicron’s severity is encouraging, while a small South African study supported anecdotal evidence the variant causes only mild illness. No doubt we will be at the mercy of COVID headlines once again.
Key macro focus this week will be US Consumer Price Index (CPI) data Friday. China Trade data comes out on Tuesday and we have gross domestic product data from the European Union and United Kingdom towards the end of the week.
The Reserve Bank of Australia meets on Tuesday and the Bank of Canada meets on Wednesday. Note, the Fed is now in a blackout period ahead of the 15 December meeting so no comments are expected.
Monday 6 December:
Tuesday 7 December:
Wednesday 8 December:
Thursday 9 December:
Friday 10 December:
Franklin Templeton Key risks & Disclaimers:
What Are the Risks?
All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. Stock prices fluctuate, sometimes rapidly and dramatically, due to factors affecting individual companies, particular industries or sectors, or general market conditions. Bond prices generally move in the opposite direction of interest rates. Thus, as prices of bonds in an investment portfolio adjust to a rise in interest rates, the value of the portfolio may decline. Investments in foreign securities involve special risks including currency fluctuations, economic instability and political developments. Investments in developing markets involve heightened risks related to the same factors, in addition to those associated with their relatively small size and lesser liquidity. Past performance is not an indicator or guarantee of future performance.
This article reflects the analysis and opinions of Franklin Templeton’s European Trading Desk as of 6th December 2021, and may vary from the analysis and opinions of other investment teams, platforms, portfolio managers or strategies at Franklin Templeton. Because market and economic conditions are often subject to rapid change, the analysis and opinions provided may change without notice. An assessment of a particular country, market, region, security, investment or strategy is not intended as an investment recommendation, nor does it constitute investment advice. Statements of fact are from sources considered reliable, but no representation or warranty is made as to their completeness or accuracy. This article does not provide a complete analysis of every material fact regarding any country, region, market, industry or security. Nothing in this document may be relied upon as investment advice or an investment recommendation. The companies named herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. Data from third-party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user. Products, services and information may not be available in all jurisdictions and are offered by FT affiliates and/or their distributors as local laws and regulations permit. Please consult your own professional adviser for further information on availability of products and services in your jurisdiction.
Issued by Franklin Templeton Investment Management Limited (FTIML) Registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL. FTIML is authorised and regulated by the Financial Conduct Authority.
This information has been accurately reproduced, as received from Franklin Templeton Investment Management Limited (FTIML). No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.
The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.
If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.